Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Cian Healthcare Ltd (CHCL.BO)

3.1200
-0.0400
(-1.27%)
At close: April 30 at 1:37:49 PM GMT+5:30
Loading Chart for CHCL.BO
  • Previous Close 3.1600
  • Open 3.2200
  • Bid 3.1300 x --
  • Ask 3.2200 x --
  • Day's Range 3.1200 - 3.2200
  • 52 Week Range 2.9700 - 4.1400
  • Volume 56,000
  • Avg. Volume 65,473
  • Market Cap (intraday) 77.987M
  • Beta (5Y Monthly) -0.01
  • PE Ratio (TTM) --
  • EPS (TTM) -6.6100
  • Earnings Date Feb 17, 2025 - Feb 18, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Cian Healthcare Limited engages in the research, development, manufacture, marketing, and sale of pharmaceutical products in India. It offers pharmaceutical products in various therapeutic areas of orthopedics, gynecology, pediatrics, cardiac, diabetic, derma-cosmetic, pain management, antibiotics, central nervous system, neuro, critical care, gastro-intestinal, and vitamins and nutrient products. The company also provides male and female infertility, energy and immunity boosting, protein supplement, arthritis and joint pain, hepatoprotective, haematinic, and pet care products, as well as herbal supplement, cosmetics, and hospital products. It offers its products in the form of tablets, capsules, soft gels, liquid orals, ointments/creams, solid formulations, sachets, lozenges, and cosmetics. In addition, the company provides contract manufacturing services. It also exports its products to various countries, such as Afghanistan, Benin, Bhutan, Bolivia, Cambodia, Sri Lanka, and Myanmar. The company was incorporated in 2003 and is based in Pune, India.

cian.co

257

Full Time Employees

March 31

Fiscal Year Ends

Recent News: CHCL.BO

View More

Performance Overview: CHCL.BO

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

CHCL.BO
19.38%
S&P BSE SENSEX (^BSESN)
2.69%

1-Year Return

CHCL.BO
20.81%
S&P BSE SENSEX (^BSESN)
7.73%

3-Year Return

CHCL.BO
20.81%
S&P BSE SENSEX (^BSESN)
40.63%

5-Year Return

CHCL.BO
20.81%
S&P BSE SENSEX (^BSESN)
137.98%

Compare To: CHCL.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CHCL.BO

View More

Valuation Measures

Annual
As of 4/30/2025
  • Market Cap

    77.99M

  • Enterprise Value

    605.57M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.17

  • Price/Book (mrq)

    0.20

  • Enterprise Value/Revenue

    1.26

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -34.29%

  • Return on Assets (ttm)

    0.08%

  • Return on Equity (ttm)

    -34.59%

  • Revenue (ttm)

    481.76M

  • Net Income Avi to Common (ttm)

    -165.19M

  • Diluted EPS (ttm)

    -6.6100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.16M

  • Total Debt/Equity (mrq)

    136.42%

  • Levered Free Cash Flow (ttm)

    311.75M

Research Analysis: CHCL.BO

View More

Company Insights: CHCL.BO

Research Reports: CHCL.BO

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.